CytoReason vs EntityMed
CytoReason vs EntityMed, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CytoReason is on 68/100 and EntityMed on 26/100.
Where each one leads
CytoReason
- our overall score: 68/100 against 26/100
- headcount: 116 against 10
- LinkedIn following: 12,830 against 1,128
EntityMed
- agent readiness: 43/100 against 21/100
- domain rating: 54/100 against 40/100
At a glance
| Measure | CytoReason | EntityMed |
|---|---|---|
| What it is | Develops a computational model of the human body for drug discovery and development. | AI-powered digital aesthetic platform predicting facial procedure outcomes for patient acquisition and engagement. |
| Category | Healthcare, Drug Discovery, Clinical Development, Biomarkers | Healthcare, Aesthetic, Simulation, Generative AI |
| Sells toBusiness model | B2B | B2B2C, B2C |
| Offering | Software | Software |
| Founded | 2016 | 2021 |
| Headquarters | Tel Aviv, Israel | Not published |
| Status | Active | Active |
Size, funding and growth
| Measure | CytoReason | EntityMed |
|---|---|---|
| Employees | 116 | 10 |
| Headcount growthLast 12 months | +13.7% | +16.9% |
| Total funding | $128M | Not published |
| Latest round | Series B | Bootstrapped |
| LinkedIn followers | 12,830 | 1,128 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CytoReason | EntityMed |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 68/100 | 26/100 |
| Traction | 60/100 | 10/100 |
| Team | 70/100 | 30/100 |
| Search visibility | 30/100 | 31/100 |
| Quality | 78/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | D (43/100) |
| Domain ratingLink authority, 0-100 | 40/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CytoReason | EntityMed |
|---|---|---|
| Hosting | Not detected | Google Cloud |
| Frameworks | Not detected | Next.js |
| Analytics | Segment | Not detected |
CytoReason vs EntityMed: common questions
Which is better, CytoReason or EntityMed?
On our 0-100 score CytoReason rates higher (68/100 against 26/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do CytoReason and EntityMed compare on the numbers?
CytoReason leads on our overall score (68/100 against 26/100), headcount (116 against 10), LinkedIn following (12,830 against 1,128). EntityMed leads on agent readiness (43/100 against 21/100), domain rating (54/100 against 40/100).
Read the full CytoReason review and pricing or the EntityMed review and pricing. You can also browse other CytoReason alternatives we track.